EMTRICITABINE/TENOFOVIR DISOPROXIL MYLAN
200MG/245MG TBL FLM 30
| SÚKL code | 0219253 |
|---|---|
| Name of the product | EMTRICITABINE/TENOFOVIR DISOPROXIL MYLAN |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | EMTRICITABINE/TENOFOVIR DISOPROXIL MYLAN |
| Supplement | 200MG/245MG TBL FLM 30 |
| Strenght | 200MG/245MG |
| Pharmaceutical form | Film-coated tablet |
| Package | 30 |
| Route | Oral use |
| Wrap type | Blister |
| Legal status | na lékařský předpis |
| Active substance |
EMTRICITABINE (EMTRICITABINUM) TENOFOVIR DISOPROXIL MALEATE (TENOFOVIRI DISOPROXILI MALEAS) |
| ATC group | J05AR03 |
| ATC group name | TENOFOVIR-DISOPROXIL A EMTRICITABIN |
Marketing authorisation information
| Registration Number | EU/1/16/1133/003 |
|---|---|
| Type of MA | centralised without orphans |
| MA status | R - active MA/authorised medicinal product |
| MA Holder | Mylan S.A.S., Saint-Priest |
| MA Holder country | FRANCIE |
cz